Organization

Fu-Dong Shi

1 clinical trial

Clinical trial

Single-center, Open Label Trial of ACTEMRA® (Tocilizumab) as Monotherapy in Highly Active Neuromyelitis Optica Spectrum Disorders (NMOSD)

Status: Completed, Estimated PCD: 2018-02-15